Viewing Study NCT00134134


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-26 @ 12:56 AM
Study NCT ID: NCT00134134
Status: COMPLETED
Last Update Posted: 2006-09-11
First Post: 2005-08-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa
Sponsor: NYU Langone Health
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module